信邦制药
(002390)
| 流通市值：61.11亿 | | | 总市值：61.62亿 |
| 流通股本：19.28亿 | | | 总股本：19.44亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,466,968,985.57 | 1,263,351,831.76 | 5,619,564,836.88 | 4,266,285,288.11 |
| 营业总成本 | 2,327,110,195.38 | 1,191,141,535.16 | 5,295,462,160.32 | 4,026,405,575.21 |
| 其他经营收益 | | | | |
| 营业利润 | 155,231,042.63 | 75,814,472.31 | 237,278,026.84 | 235,401,821.84 |
| 利润总额 | 153,729,472.09 | 76,271,267.32 | 229,964,735.61 | 225,227,401.91 |
| 净利润 | 136,123,428.32 | 64,557,521.35 | 191,795,599.53 | 200,777,172.16 |
| 每股收益 | | | | |
| 其他综合收益 | -24,162,915.62 | - | 72,929,458.43 | - |
| 综合收益总额 | 111,960,512.7 | 64,557,521.35 | 264,725,057.96 | 200,777,172.16 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,757,441,752.67 | 4,863,642,055.79 | 4,843,043,908.54 | 4,931,127,113.23 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,633,070,404.48 | 3,700,076,546.27 | 3,747,458,496.25 | 3,660,723,452.1 |
| 资产总计 | 8,390,512,157.15 | 8,563,718,602.06 | 8,590,502,404.79 | 8,591,850,565.33 |
| 流动负债: | | | | |
| 流动负债合计 | 1,312,692,188.95 | 1,389,309,368.05 | 1,463,978,378.9 | 1,379,477,295.6 |
| 非流动负债: | | | | |
| 非流动负债合计 | 89,611,244.05 | 72,044,121.53 | 88,716,434.76 | 238,503,625.22 |
| 负债合计 | 1,402,303,433 | 1,461,353,489.58 | 1,552,694,813.66 | 1,617,980,920.82 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,751,497,719.41 | 6,838,515,236.15 | 6,789,858,736.9 | 6,748,968,461.42 |
| 股东权益合计 | 6,988,208,724.15 | 7,102,365,112.48 | 7,037,807,591.13 | 6,973,869,644.51 |
| 负债和股东权益合计 | 8,390,512,157.15 | 8,563,718,602.06 | 8,590,502,404.79 | 8,591,850,565.33 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,756,807,794.43 | 1,263,866,501.99 | 5,989,784,466.03 | 4,489,250,989.78 |
| 经营活动现金流出小计 | 2,355,518,333.82 | 1,218,355,150.21 | 5,257,253,843.52 | 4,027,668,687.42 |
| 经营活动产生的现金流量净额 | 401,289,460.61 | 45,511,351.78 | 732,530,622.51 | 461,582,302.36 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 628,828,009.28 | 301,417,453.27 | 246,906,267.81 | 11,130,834.73 |
| 投资活动现金流出小计 | 618,873,585.71 | 302,042,391.02 | 285,420,518.87 | 66,335,825.59 |
| 投资活动产生的现金流量净额 | 9,954,423.57 | -624,937.75 | -38,514,251.06 | -55,204,990.86 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 324,358,466.29 | 192,358,466.29 | 522,795,072.56 | 464,795,072.56 |
| 筹资活动现金流出小计 | 422,287,079.08 | 180,753,327.52 | 1,110,008,214.78 | 882,718,383.49 |
| 筹资活动产生的现金流量净额 | -97,928,612.79 | 11,605,138.77 | -587,213,142.22 | -417,923,310.93 |
| 汇率变动对现金及现金等价物的影响 | -2,093.14 | -1,328.77 | 3,141.57 | -1,859.81 |
| 现金及现金等价物净增加额 | 313,313,178.25 | 56,490,224.03 | 106,806,370.8 | -11,547,859.24 |
| 期末现金及现金等价物余额 | 1,352,839,789.89 | 1,096,016,835.67 | 1,039,526,611.64 | 921,172,381.6 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 313,313,178.25 | - | 106,806,370.8 | - |